What are the main factors affecting the outcome of tocilizumab therapy in COVID-19-induced cytokine release syndrome?
Cansu Akleylek, Seray Gizem Gür, Ibrahim Halil Sever, Safiye Koçulu Demir, Esin Cevik, Egemen Eken, Zafer Gökkaya, Yonca Çağatay, Neslihan Yılmaz
(Eur J Rheumatol 2022; 9: 126-131) DOI: 10.5152/eurjrheum.2022.21010